Some directors and executives of GLORIA PHARMA plan to reduce their holdings by a total of no more than 1.4346 million shares
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, GLORIA PHARMA announced that on May 29, 2025, the company received a "Share Reduction Plan Notification Letter" issued by Mr. Li Runbao, Vice President, Mr. Wang Xiaohang, Vice President, and Ms. Liu Yueyin, Director, Vice President, and Board Secretary, stating that the aforementioned individuals plan to reduce their holdings by a total of no more than 1.4346 million shares
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments